Video

Viewing Lung Cancer as a Chronic Disease

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of a man in a suit.
Image of man with black hair.
Image of man with gray hair.
Image of Dr. Minesh Mehta at ASCO 2024.
Related Content
Illustration of woman with dark brown hair.
March 11th 2025

Surviving Life-Threatening Lung Cancer: Lessons Learned

Sue McCarthy
Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Illustration of lungs.
March 2nd 2025

First Patient With Small Cell Lung Cancer Dosed With Peluntamig

Spencer Feldman
The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Illustration of lungs.
February 27th 2025

Datroway May Be Effective in Non-Small Cell Lung Cancer Subtypes

Spencer Feldman
Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic alterations, including EGFR and ALK subgroups.
Illustration of lung.
February 25th 2025

Neoadjuvant Opdivo Combo Elicits Statistically Significant OS Findings in Resectable NSCLC

Ryan Scott
Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus chemo alone in resectable NSCLC.